Asialoglycoprotein receptor mediated hepatocyte targeting - Strategies and applications

Journal of Controlled Release

Volumn 203, Issue , 2015, Pages 126-139

  D'Souza, Anisha A ^a   Devarajan, Padma V ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Asialoglycoprotein receptor; Galactose; Hepatocytes; Ligands; Pullulan; Sugars

Indexed keywords

CARBOHYDRATES; DRUG DELIVERY; MOLECULAR BIOLOGY; POLYMERS; SUGARS;

ASIALOGLYCOPROTEIN RECEPTORS; CARBOHYDRATE POLYMERS; GALACTOSE; HEPATOCYTE TARGETING; HEPATOCYTES; LIGAND-RECEPTOR BINDING; PULLULANS; TARGETED DELIVERY;

LIGANDS;

ASIALOGLYCOPROTEIN RECEPTOR; CARBOHYDRATE; GALACTOSE; GLYCOPROTEIN; LIGAND; LIPID; NANOCARRIER; POLYMER; SUGAR; DRUG; DRUG CARRIER; GLUCAN; NANOMATERIAL; PULLULAN;

CALCIUM BINDING; CONJUGATE; DENSITY; DIAGNOSIS; DRUG DELIVERY SYSTEM; GEOMETRY; HUMAN; HYDROPHILICITY; HYDROPHOBICITY; INTERNALIZATION; ISOMER; LIGAND BINDING; LIVER; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN TARGETING; RETICULOENDOTHELIAL SYSTEM; REVIEW; TISSUE ENGINEERING; ANIMAL; CARBOHYDRATE METABOLISM; CHEMICAL STRUCTURE; CHEMISTRY; ENDOCYTOSIS; METABOLISM; PROCEDURES;

ANIMALS; ASIALOGLYCOPROTEIN RECEPTOR; CARBOHYDRATE METABOLISM; CARBOHYDRATES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ENDOCYTOSIS; GALACTOSE; GLUCANS; HEPATOCYTES; HUMANS; LIGANDS; MODELS, MOLECULAR; NANOSTRUCTURES; PHARMACEUTICAL PREPARATIONS;

EID: 84923560851     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.02.022     Document Type: Review

References (244)

1. R. Mazzanti, L. Gramantieri, and L. Bolondi Hepatocellular carcinoma: epidemiology and clinical aspects Mol. Asp. Med. 29 2008 130 143
2. D. Lavanchy Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures J. Viral Hepat. 11 2004 97 107
3. WHO Malaria, Fact sheet N94 2014 World Health Organization
4. K. Poelstra, J. Prakash, and L. Beljaars Drug targeting to the diseased liver J. Control. Release 161 2012 188 197
5. S. Kawakami, and M. Hashida Glycosylation-mediated targeting of carriers J. Control. Release 190 2014 542 555
6. P.K. Grewal Chapter thirteen - the Ashwell-Morell receptor F. Minoru, Methods in Enzymology 2010 Academic Press 223 241
7. R.J. Stockert The asialoglycoprotein receptor: relationships between structure, function, and expression Physiol. Rev. 75 1995 591 609
8. R.L. Harris, C.W. van der Berg, and D.J. Bowen ASGR1 and ASGR2, the genes that encode the asialoglycoprotein receptor (Ashwell receptor), are expressed in peripheral blood monocytes and show interindividual differences in transcript profile Mol. Biol. Int. 2012 2012 10
9. M. Dodeur, D. Durand, J. Dumont, G. Durand, J. Feger, and J. Agneray Effects of streptozotocin-induced diabetes mellitus on the binding and uptake of asialoorosomucoid by isolated hepatocytes from rats Eur. J. Biochem. 123 1982 383 387
10. Y. Li, G. Huang, J. Diakur, and L.I. Wiebe Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development Curr. Drug Deliv. 5 2008 299 302
11. R. Cummings, and R. McEver C-type Lectins A. Varki, R. Cummings, J. Esko, Essentials of Glycobiology 2009 Cold Spring Harbor Laboratory Press Cold Spring Harbor (NY)
12. T. Onizuka, H. Shimizu, Y. Moriwaki, T. Nakano, S. Kanai, I. Shimada, and H. Takahashi NMR study of ligand release from asialoglycoprotein receptor under solution conditions in early endosomes FEBS J. 279 2012 2645 2656
13. A.A. D'Souza, P. Jain, C.N. Galdhar, A. Samad, M.S. Degani, and P.V. Devarajan Comparative in silico-in vivo evaluation of ASGP-R ligands for hepatic targeting of curcumin Gantrez nanoparticles AAPS J. 15 2013 696 706
14. J. Wu, M.H. Nantz, and M.A. Zern Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications Front. Biosci. 7 2002 d717 725
15. S.K. Ramadugu, Y.H. Chung, E.J. Fuentes, K.G. Rice, and C.J. Margulis In silico prediction of the 3D structure of trimeric asialoglycoprotein receptor bound to triantennary oligosaccharide J. Am. Chem. Soc. 132 2010 9087 9095
16. D.D. McAbee, X. Jiang, and K.B. Walsh Lactoferrin binding to the rat asialoglycoprotein receptor requires the receptor's lectin properties Biochem. J. 348 2000 113 117
17. G. Sahay, D.Y. Alakhova, and A.V. Kabanov Endocytosis of nanomedicines J. Control. Release 145 2010 182 195
18. T. Tanabe, W.E. Pricer Jr., and G. Ashwell Subcellular membrane topology and turnover of a rat hepatic binding protein specific for asialoglycoproteins J. Biol. Chem. 254 1979 1038 1043
19. C.M. Varga, T.J. Wickham, and D.A. Lauffenburger Receptor-mediated targeting of gene delivery vectors: insights from molecular mechanisms for improved vehicle design Biotechnol. Bioeng. 70 2000 593 605
20. A.L. Schwartz, A. Bolognesi, and S.E. Fridovich Recycling of the asialoglycoprotein receptor and the effect of lysosomotropic amines in hepatoma cells J. Cell Biol. 98 1984 732 738
21. A.L. Schwartz, S.E. Fridovich, and H.F. Lodish Kinetics of internalization and recycling of the asialoglycoprotein receptor in a hepatoma cell line J. Biol. Chem. 257 1982 4230 4237
22. R. Warren, and D. Doyle Turnover of the surface proteins and the receptor for serum asialoglycoproteins in primary cultures of rat hepatocytes J. Biol. Chem. 256 1981 1346 1355
23. H.-X. Wang, M.-H. Xiong, Y.-C. Wang, J. Zhu, and J. Wang N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver J. Control. Release 166 2013 106 114
24. A.R. Kolatkar, A.K. Leung, R. Isecke, R. Brossmer, K. Drickamer, and W.I. Weis Mechanism of N-acetylgalactosamine binding to a C-type animal lectin carbohydrate-recognition domain J. Biol. Chem. 273 1998 19502 19508
25. N.I. Ruiz, and K. Drickamer Differential ligand binding by two subunits of the rat liver asialoglycoprotein receptor Glycobiology 6 1996 551 559
26. R. Mukthavaram, S. Marepally, M.Y. Venkata, G.N. Vegi, R. Sistla, and A. Chaudhuri Cationic glycolipids with cyclic and open galactose head groups for the selective targeting of genes to mouse liver Biomaterials 30 2009 2369 2384
27. E.J.F. Franssen, R.W. Jansen, M. Vaalburg, and D.K.F. Meijer Hepatic and intrahepatic targeting of an anti-inflammatory agent with human serum albumin and neoglycoproteins as carrier molecules Biochem. Pharmacol. 45 1993 1215 1226
28. S. Kawakami, F. Yamashita, K. Nishida, J. Nakamura, and M. Hashida Glycosylated cationic liposomes for cell-selective gene delivery Crit. Rev. Ther. Drug Carrier Syst. 19 2002 171 190
29. D. Stokmaier, O. Khorev, B. Cutting, R. Born, D. Ricklin, T.O. Ernst, F. Boni, K. Schwingruber, M. Gentner, M. Wittwer, M. Spreafico, A. Vedani, S. Rabbani, O. Schwardt, and B. Ernst Design, synthesis and evaluation of monovalent ligands for the asialoglycoprotein receptor ASGP-R Bioorg. Med. Chem. 17 2009 7254 7264
30. M. Nishikawa Development of cell-specific targeting systems for drugs and genes Biol. Pharm. Bull. 28 2005 195 200
31. C. Managit, S. Kawakami, M. Nishikawa, F. Yamashita, and M. Hashida Targeted and sustained drug delivery using PEGylated galactosylated liposomes Int. J. Pharm. 266 2003 77 84
32. T.C. Wong, R.R. Townsend, and Y.C. Lee Synthesis of D-galactosamine derivatives and binding studies using isolated rat hepatocytes Carbohydr. Res. 170 1987 27 46
33. F. Staud, M. Nishikawa, Y. Takakura, and M. Hashida Liver uptake and hepato-biliary transfer of galactosylated proteins in rats are determined by the extent of galactosylation Biochim. Biophys. Acta 1427 1999 183 192
34. M. Nishikawa, S. Takemura, Y. Takakura, and M. Hashida Targeted delivery of plasmid DNA to hepatocytes in vivo: optimization of the pharmacokinetics of plasmid DNA/galactosylated poly(ε-lysine) complexes by controlling their physicochemical properties J. Pharmacol. Exp. Ther. 287 1998 408 415
35. M. Hashida, M. Nishikawa, F. Yamashita, and Y. Takakura Cell-specific delivery of genes with glycosylated carriers Adv. Drug Deliv. Rev. 52 2001 187 196
36. R.T. Lee, M.H. Wang, W.J. Lin, and Y.C. Lee New and more efficient multivalent glyco-ligands for asialoglycoprotein receptor of mammalian hepatocytes Bioorg. Med. Chem. 19 2011 2494 2500
37. E.A. Biessen, D.M. Beuting, H.C. Roelen, G.A. van de Marel, J.H. van Boom, and T.J. van Berkel Synthesis of cluster galactosides with high affinity for the hepatic asialoglycoprotein receptor J. Med. Chem. 38 1995 1538 1546
38. P.C. Rensen, R.L. de Vrueh, J. Kuiper, M.K. Bijsterbosch, E.A. Biessen, and T.J. van Berkel Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting Adv. Drug Deliv. Rev. 47 2001 251 276
39. D.T. Connolly, R.R. Townsend, K. Kawaguchi, W.R. Bell, and Y.C. Lee Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation J. Biol. Chem. 257 1982 939 945
40. U. Westerlind, J. Westman, E. Tornquist, C.I. Smith, S. Oscarson, M. Lahmann, and T. Norberg Ligands of the asialoglycoprotein receptor for targeted gene delivery, part 1: synthesis of and binding studies with biotinylated cluster glycosides containing N-acetylgalactosamine Glycoconj. J. 21 2004 227 241
41. M. Singh, and M. Ariatti Targeted gene delivery into HepG2 cells using complexes containing DNA, cationized asialoorosomucoid and activated cationic liposomes J. Control. Release 92 2003 383 394
42. K.G. Rice, O.A. Weisz, T. Barthel, R.T. Lee, and Y.C. Lee Defined geometry of binding between triantennary glycopeptide and the asialoglycoprotein receptor of rat heptocytes J. Biol. Chem. 265 1990 18429 18434
43. Y.C. Lee Biochemistry of carbohydrate-protein interaction FASEB J. 6 1992 3193 3200
44. D.H. Joziasse, R.T. Lee, Y.C. Lee, E.A. Biessen, W.E. Schiphorst, C.A. Koeleman, and D.H.v.d. Eijnden a3-Galactosylated glycoproteins can bind to the hepatic asialoglycoprotein receptor Eur. J. Biochem. 267 2000 6501
45. B. Saunier, M. Triyatni, L. Ulianich, P. Maruvada, P. Yen, and L.D. Kohn Role of the asialoglycoprotein receptor in binding and entry of hepatitis C virus structural proteins in cultured human hepatocytes J. Virol. 77 2003 546 559
46. L.A. Sliedregt, P.C. Rensen, E.T. Rump, P.J. van Santbrink, M.K. Bijsterbosch, A.R. Valentijn, G.A. van der Marel, J.H. van Boom, T.J. van Berkel, and E.A. Biessen Design and synthesis of novel amphiphilic dendritic galactosides for selective targeting of liposomes to the hepatic asialoglycoprotein receptor J. Med. Chem. 42 1999 609 618
47. C. Managit, S. Kawakami, F. Yamashita, and M. Hashida Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes J. Pharm. Sci. 94 2005 2266 2275
48. D.D. McAbee, and X. Jiang Copper and zinc ions differentially block asialoglycoprotein receptor-mediated endocytosis in isolated rat hepatocytes J. Biol. Chem. 274 1999 14750 14758
49. I. Geffen, and M. Spiess Phorbol ester-induced redistribution of the ASGP receptor is independent of receptor phosphorylation FEBS Lett. 305 1991 209 212
50. E.M. Kim, H.J. Jeong, S.L. Kim, M.H. Sohn, J.W. Nah, H.S. Bom, I.K. Park, and C.S. Cho Asialoglycoprotein-receptor-targeted hepatocyte imaging using 99mTc galactosylated chitosan Nucl. Med. Biol. 33 2006 529 534
51. M.T. Debanne, W.H. Evans, N. Flint, and E. Regoeczi Receptor-rich intracellular membrane vesicles transporting asialotransferrin and insulin in liver Nature 298 1982 398 400
52. L. Fiume, G.D. Stefano, C. Busi, A. Mattioli, F. Bonino, M. Torrani-Cerenzia, G. Verme, M. Rapicetta, M. Bertini, and G.B. Gervasi Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor J. Viral Hepat. 4 1997 363 370
53. T.D. McKee, M.E. DeRome, G.Y. Wu, and M.A. Findeis Preparation of asialoorosomucoid-polylysine conjugates Bioconjug. Chem. 5 1994 306 311
54. M.A. Arangoa, N. Duzgunes, and C. Tros de Ilarduya Increased receptor-mediated gene delivery to the liver by protamine-enhanced-asialofetuin-lipoplexes Gene Ther. 10 2003 5 14
55. L. Fiume, G. Di Stefano, C. Busi, A. Mattioli, G. Battista Gervasi, M. Bertini, C. Bartoli, R. Catalani, G. Caccia, C. Farina, A. Fissi, O. Pieroni, R. Giuseppetti, E. D'Ugo, R. Bruni, and M. Rapicetta Hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly-ε-lysine. Synthesis of the carrier and pharmacological properties of the conjugate J. Hepatol. 26 1997 253 259
56. E. Regoeczi, M.T. Debanne, M.C. Hatton, and A. Koj Elimination of asialofetuin and asialoorosomucoid by the intact rat. Quantitative aspects of the hepatic clearance mechanism Biochim. Biophys. Acta 541 1978 372 384
57. N. Mishra, N.P. Yadav, V.K. Rai, P. Sinha, K.S. Yadav, S. Jain, and S. Arora Efficient hepatic delivery of drugs: novel strategies and their significance Biomed. Res. Int. 2013 2013 382184
58. T. Tanaka, Y. Fujishima, S. Hamano, and Y. Kaneo Cellular disposition of arabinogalactan in primary cultured rat hepatocytes Eur. J. Pharm. Sci. 22 2004 435 444
59. Y. Kaneo, T. Ueno, T. Tanaka, H. Iwase, Y. Yamaguchi, and T. Uemura Pharmacokinetics and biodisposition of fluorescein-labeled arabinogalactan in rats Int. J. Pharm. 201 2000 59 69
60. G.S. Kelly Larch arabinogalactan: clinical relevance of a novel immune-enhancing polysaccharide Altern. Med. Rev. 4 1999 96 103
61. J. Beuth, H.L. Ko, K. Oette, G. Pulverer, K. Roszkowski, and G. Uhlenbruck Inhibition of liver metastasis in mice by blocking hepatocyte lectins with arabinogalactan infusions and d-galactose J. Cancer Res. Clin. Oncol. 113 1987 51 55
62. C. Bertoldo, M. Armbrecht, F. Becker, T. Schafer, G. Antranikian, and W. Liebl Cloning, sequencing, and characterization of a heat- and alkali-stable type I pullulanase from Anaerobranca gottschalkii Appl. Environ. Microbiol. 70 2004 3407 3416
63. M. Gupta, and A.K. Gupta In vitro cytotoxicity studies of hydrogel pullulan nanoparticles prepared by AOT/N-hexane micellar system J. Pharm. Pharm. Sci. 7 2004 38 46
64. T. Tanaka, S. Hamano, Y. Fujishima, and Y. Kaneo Uptake of pullulan in cultured rat liver parenchymal cells Biol. Pharm. Bull. 28 2005 560 562
65. Y. Kaneo, T. Tanaka, T. Nakano, and Y. Yamaguchi Evidence for receptor-mediated hepatic uptake of pullulan in rats J. Control. Release 70 2001 365 373
66. A. San Juan, H. Hlawaty, F. Chaubet, D. Letourneur, and L.J. Feldman Cationized pullulan 3D matrices as new materials for gene transfer J. Biomed. Mater. Res. A 82 2007 354 362
67. H. Yim, S.G. Yang, Y.S. Jeon, I.S. Park, M. Kim, D.H. Lee, Y.H. Bae, and K. Na The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI Biomaterials 32 2011 5187 5194
68. J. Jo, T. Ikai, A. Okazaki, M. Yamamoto, Y. Hirano, and Y. Tabata Expression profile of plasmid DNA by spermine derivatives of pullulan with different extents of spermine introduced J. Control. Release 118 2007 389 398
69. C.-Y. Yu, Y.-M. Wang, N.-M. Li, G.-S. Liu, S. Yang, G.-T. Tang, D.-X. He, X.-W. Tan, and H. Wei In vitro and in vivo evaluation of pectin-based nanoparticles for hepatocellular carcinoma drug chemotherapy Mol. Pharm. 11 2014 638 644
70. Y. Maitani, K. Kawano, K. Yamada, T. Nagai, and K. Takayama Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells J. Control. Release 75 2001 381 389
71. K. Shimizu, Y. Maitani, K. Takayama, and T. Nagai Formulation of liposomes with a soybean-derived sterylglucoside mixture and cholesterol for liver targeting Biol. Pharm. Bull. 20 1997 881 886
72. S. Ghiamkazemi, A. Amanzadeh, R. Dinarvand, M. Rafiee-Tehrani, and M. Amini Synthesis, and characterization, and evaluation of cellular effects of the FOL-PEG-g-PEI-GAL nanoparticles as a potential non-viral vector for gene delivery J. Nanomater. 10 2010
73. W. Meng, K.-H. Jung, I.-K. Kang, O. Kwon, and T. Akaike Immobilization of lactobionic acid on polyurethane films and their interaction with hepatocytes Macromol. Res. 13 2005 257 264
74. H.H. Spanjer, and G.L. Scherphof Targeting of lactosylceramide-containing liposomes to hepatocytes in vivo Biochim. Biophys. Acta 734 1983 40 47
75. J.U. Baenziger, and Y. Maynard Human hepatic lectin-physiochemical properties and specificity J. Biol. Chem. 255 1980 7
76. R.F. Rotundo, R.A. Rebres, P.J. McKeown-Longo, F.A. Blumenstock, and T.M. Saba Circulating cellular fibronectin may be a natural ligand for the hepatic asialoglycoprotein receptor: possible pathway for fibronectin deposition and turnover in the rat liver Hepatology 28 1998 475 485
77. K. Akamatsu, M. Imai, Y. Yamasaki, M. Nishikawa, Y. Takakura, and M. Hashida Disposition characteristics of glycosylated poly(amino acids) as liver cell-specific drug carrier J. Drug Target. 6 1998 229 239
78. H. Hirabayashi, M. Nishikawa, Y. Takakura, and M. Hashida Development and pharmacokinetics of galactosylated poly-ε-glutamic acid as a biodegradable carrier for liver-specific drug delivery Pharm. Res. 13 1996 880 884
79. H.-F. Liang, T.-F. Yang, C.-T. Huang, M.-C. Chen, and H.-W. Sung Preparation of nanoparticles composed of poly(γ-glutamic acid)-poly(lactide) block copolymers and evaluation of their uptake by HepG2 cells J. Control. Release 105 2005 213 225
80. Z. Qin, W. Liu, L. Li, L. Guo, C. Yao, and X. Li Galactosylated N-2-hydroxypropyl methacrylamide-b-N-3-guanidinopropyl methacrylamide block copolymers as hepatocyte-targeting gene carriers Bioconjug. Chem. 22 2011 1503 1512
81. H.-L. Jiang, J.-T. Kwon, E.-M. Kim, Y.-K. Kim, R. Arote, D. Jere, H.-J. Jeong, M.-K. Jang, J.-W. Nah, C.-X. Xu, I.-K. Park, M.-H. Cho, and C.-S. Cho Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting J. Control. Release 131 2008 150 157
82. I.K. Park, Y.H. Park, B.A. Shin, E.S. Choi, Y.R. Kim, T. Akaike, and C.S. Cho Galactosylated chitosan-graft-dextran as hepatocyte-targeting DNA carrier J. Control. Release 69 2000 97 108
83. Y. Kato, H. Onishi, and Y. Machida Biological characteristics of lactosaminated N-succinyl-chitosan as a liver-specific drug carrier in mice J. Control. Release 70 2001 295 307
84. S.E. Cook, I.K. Park, E.M. Kim, H.J. Jeong, T.G. Park, Y.J. Choi, T. Akaike, and C.S. Cho Galactosylated polyethylenimine-graft-poly(vinyl pyrrolidone) as a hepatocyte-targeting gene carrier J. Control. Release 105 2005 151 163
85. K. Kunath, A. von Harpe, D. Fischer, and T. Kissel Galactose-PEI-DNA complexes for targeted gene delivery: degree of substitution affects complex size and transfection efficiency J. Control. Release 88 2003 159 172
86. S. Sonoke, T. Ueda, K. Fujiwara, K. Kuwabara, and J. Yano Galactose-modified cationic liposomes as a liver-targeting delivery system for small interfering RNA Biol. Pharm. Bull. 34 2011 1338 1342
87. M. Zhang, X. Zhou, B. Wang, B.C. Yung, L.J. Lee, K. Ghoshal, and R.J. Lee Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma J. Control. Release 168 2013 251 261
88. K. Shigeta, S. Kawakami, Y. Higuchi, T. Okuda, H. Yagi, F. Yamashita, and M. Hashida Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells J. Control. Release 118 2007 262 270
89. S.N. Wang, Y.H. Deng, H. Xu, H.B. Wu, Y.K. Qiu, and D.W. Chen Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin Eur. J. Pharm. Biopharm. 62 2006 32 38
90. J. Ding, C. Xiao, Y. Li, Y. Cheng, N. Wang, C. He, X. Zhuang, X. Zhu, and X. Chen Efficacious hepatoma-targeted nanomedicine self-assembled from galactopeptide and doxorubicin driven by two-stage physical interactions J. Control. Release 169 2013 193 203
91. M.J. Schindl, A.M. Millar, D.N. Redhead, K.C. Fearon, J.A. Ross, C.H. Dejong, O.J. Garden, and S.J. Wigmore The adaptive response of the reticuloendothelial system to major liver resection in humans Ann. Surg. 243 2006 507 514
92. H. Hillaireau, and P. Couvreur Nanocarriers' entry into the cell: relevance to drug delivery Cell. Mol. Life Sci. 66 2009 2873 2896
93. G.Y. Wu, and C.H. Wu Receptor-mediated in vitro gene transformation by a soluble DNA carrier system J. Biol. Chem. 262 1987 4429 4432
94. L. Fiume, A. Mattioli, P.G. Balboni, M. Tognon, G. Barbanti-Brodano, J. de Vries, and T. Wieland Enhanced inhibition of virus DNA synthesis in hepatocytes by trifluorothymidine coupled to asialofetuin FEBS Lett. 103 1979 47 51
95. L. Fiume, C. Busi, P. Preti, and G. Spinosa Conjugates of ara-AMP with lactosaminated albumin: a study on their immunogenicity in mouse and rat Cancer Drug Deliv. 4 1987 145 150
96. J.R. Merwin, G.S. Noell, W.L. Thomas, H.C. Chiou, M.E. DeRome, T.D. McKee, G.L. Spitalny, and M.A. Findeis Targeted delivery of DNA using YEE(GalNAcAH)3, a synthetic glycopeptide ligand for the asialoglycoprotein receptor Bioconjug. Chem. 5 1994 612 620
97. Y. Suginoshita, Y. Tabata, T. Matsumura, Y. Toda, M. Nabeshima, F. Moriyasu, Y. Ikada, and T. Chiba Liver targeting of human interferon-beta with pullulan based on metal coordination J. Control. Release 83 2002 75 88
98. K. Akamatsu, Y. Yamasaki, M. Nishikawa, Y. Takakura, and M. Hashida Development of a hepatocyte-specific prostaglandin E(1) polymeric prodrug and its potential for preventing carbon tetrachloride-induced fulminant hepatitis in mice J. Pharmacol. Exp. Ther. 290 1999 1242 1249
99. G. Di Stefano, F.P. Colonna, A. Bongini, C. Busi, A. Mattioli, and L. Fiume Ribavirin conjugated with lactosaminated poly-ε-lysine: selective delivery to the liver and increased antiviral activity in mice with viral hepatitis Biochem. Pharmacol. 54 1997 357 363
100. J. Ma, C. Huang, X. Yao, C. Shi, L. Sun, L. Yuan, P. Lei, H. Zhu, H. Liu, X. Wu, Q. Ning, C. Zhou, and G. Shen Inhibition of hepatitis B virus and induction of hepatoma cell apoptosis by ASGPR-directed delivery of shRNAs PLoS One 2012 e46096
101. G. Di Stefano, C. Busi, A. Camerino, B. Nardo, and L. Fiume Enhanced liver blood concentrations of adenine arabinoside accomplished by lactosaminated poly-ε-lysine coupling: implications for regional chemotherapy of hepatic micrometastases Biochem. Pharmacol. 59 2000 301 304
102. D.J. Peng, J. Sun, Y.Z. Wang, J. Tian, Y.H. Zhang, M.H. Noteborn, and S. Qu Inhibition of hepatocarcinoma by systemic delivery of apoptin gene via the hepatic asialoglycoprotein receptor Cancer Gene Ther. 14 2007 66 73
103. H.M. Hu, X. Zhang, N.Q. Zhong, and S.R. Pan Study on galactose-poly(ethylene glycol)-poly(L-lysine) as novel gene vector for targeting hepatocytes in vitro J. Biomater. Sci. Polym. Ed. 23 2012 677 695
104. K. Sagara, and S.W. Kim A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes J. Control. Release 79 2002 271 281
105. Z.Y. Ong, C. Yang, S.J. Gao, X.-Y. Ke, J.L. Hedrick, and Y. Yan Yang Galactose-functionalized cationic polycarbonate diblock copolymer for targeted gene delivery to hepatocytes Macromol. Rapid Commun. 34 2013 1714 1720
106. T.H. Kim, I.K. Park, J.W. Nah, Y.J. Choi, and C.S. Cho Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier Biomaterials 25 2004 3783 3792
107. X.C. Yang, Y.L. Niu, N.N. Zhao, C. Mao, and F.J. Xu A biocleavable pullulan-based vector via ATRP for liver cell-targeting gene delivery Biomaterials 35 2014 3873 3884
108. K. Maruyama, F. Iwasaki, T. Takizawa, H. Yanagie, T. Niidome, E. Yamada, T. Ito, and Y. Koyama Novel receptor-mediated gene delivery system comprising plasmid/protamine/sugar-containing polyanion ternary complex Biomaterials 25 2004 3267 3273
109. J.W. Hopewel, R. Duncan, D. Wilding, and K. Chakrabarti Preclinical evaluation of the cardiotoxicity of PK2: a novel HPMA copolymer-doxorubicin-galactosamine conjugate antitumour agent Hum. Exp. Toxicol. 20 2001 461 470
110. L.W. Seymour, D.R. Ferry, D. Anderson, S. Hesslewood, P.J. Julyan, R. Poyner, J. Doran, A.M. Young, S. Burtles, and D.J. Kerr Hepatic drug targeting: phase I evaluation of polymer-bound doxorubicin J. Clin. Oncol. 20 2002 1668 1676
111. P.J. Julyan, L.W. Seymour, D.R. Ferry, S. Daryani, C.M. Boivin, J. Doran, M. David, D. Anderson, C. Christodoulou, A.M. Young, S. Hesslewood, and D.J. Kerr Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine J. Control. Release 57 1999 281 290
112. J. Liu, and Y. Tabata Photodynamic therapy of fullerene modified with pullulan on hepatoma cells J. Drug Target. 18 2010 602 610
113. J.H. Han, Y.K. Oh, D.S. Kim, and C.K. Kim Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier Int. J. Pharm. 188 1999 39 47
114. T. Ishihara, A. Kano, K. Obara, M. Saito, X. Chen, T.G. Park, T. Akaike, and A. Maruyama Nuclear localization and antisense effect of PNA internalized by ASGP-R-mediated endocytosis with protein/DNA conjugates J. Control. Release 155 2011 34 39
115. M. Hashida, S. Takemura, M. Nishikawa, and Y. Takakura Targeted delivery of plasmid DNA complexed with galactosylated poly(ε-lysine) J. Control. Release 53 1998 301 310
116. A. Dehshahri, R.K. Oskuee, W.T. Shier, and M. Ramezani β-Galactosylated Alkyl-oligoamine Derivatives of Polyethylenimine Enhanced pDNA Delivery into Hepatic Cells with Reduced Toxicity, Curr. Nanosci. 8 8. 2012 World Health Organization
117. T. Aoyama, O. Ogawa, and Y. Tabata Liver targeting of plasmid DNA by pullulan conjugation based on metal coordination J. Control. Release 83 2002 287 302
118. L. Zhu, and R.I. Mahato Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation Bioconjug. Chem. 21 2010 2119 2127
119. N. Tomiya, J.G. Jardim, J. Hou, R. Pastrana-Mena, R.R. Dinglasan, and Y.C. Lee Liver-targeting of primaquine-(poly-gamma-glutamic acid) and its degradation in rat hepatocytes Bioorg. Med. Chem. 21 2013 5275 5281
120. J.M. Wilson, M. Grossman, C.H. Wu, N.R. Chowdhury, G.Y. Wu, and J.R. Chowdhury Hepatocyte-directed gene transfer in vivo leads to transient improvement of hypercholesterolemia in low density lipoprotein receptor-deficient rabbits J. Biol. Chem. 267 1992 963 967
121. T. Iyanagi, Y. Emi, and S. Ikushiro Biochemical and molecular aspects of genetic disorders of bilirubin metabolism Biochim. Biophys. Acta 1407 1998 173 184
122. M. Hashida, H. Hirabayashi, M. Nishikawa, and Y. Takakura Targeted delivery of drugs and proteins to the liver via receptor-mediated endocytosis J. Control. Release 46 1997 129 137
123. S. Muro Challenges in design and characterization of ligand-targeted drug delivery systems J. Control. Release 164 2012 125 137
124. Y. Singh, M. Palombo, and P.J. Sinko Recent trends in targeted anticancer prodrug and conjugate design Curr. Med. Chem. 15 2008 1802 1826
125. L. Fiume, A. Mattioli, C. Busi, and C. Accorsi Selective penetration and pharmacological activity of lactosaminated albumin conjugates of adenine arabinoside 5-monophosphate (ara-AMP) in mouse liver Gut 25 1984 1392 1398
126. C.J. Sunderland, M. Steiert, J.E. Talmadge, A.M. Derfus, and S.E. Barry Targeted nanoparticles for detecting and treating cancer Drug Dev. Res. 67 2006 70 93
127. H.C. Arora, M.P. Jensen, Y. Yuan, A. Wu, S. Vogt, T. Paunesku, and G.E. Woloschak Nanocarriers enhance doxorubicin uptake in drug-resistant ovarian cancer cells Cancer Res. 72 2012 769 778
128. P.C. Rensen, L.A. Sliedregt, M. Ferns, E. Kieviet, S.M. van Rossenberg, S.H. van Leeuwen, T.J. van Berkel, and E.A. Biessen Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo J. Biol. Chem. 276 2001 37577 37584
129. S.R. Popielarski, S.H. Pun, and M.E. Davis A nanoparticle-based model delivery system to guide the rational design of gene delivery to the liver. 1. Synthesis and characterization Bioconjug. Chem. 16 2005 1063 1070
130. J. Schlepper-Schafer, D. Hulsmann, A. Djovkar, H.E. Meyer, L. Herbertz, H. Kolb, and V. Kolb-Bachofen Endocytosis via galactose receptors in vivo. Ligand size directs uptake by hepatocytes and/or liver macrophages Exp. Cell Res. 165 1986 494 506
131. E.A. Biessen, H. Vietsch, and T.J. Van Berkel Cholesterol derivative of a new triantennary cluster galactoside directs low- and high-density lipoproteins to the parenchymal liver cell Biochem. J. 302 Pt 1 1994 283 289
132. J. Kuiper, H.F. Bakkeren, E.A. Biessen, and T.J. Van Berkel Characterization of the interaction of galactose-exposing particles with rat Kupffer cells Biochem. J. 299 Pt 1 1994 285 290
133. K. Shimizu, X.R. Qi, Y. Maitani, M. Yoshii, K. Kawano, K. Takayama, and T. Nagai Targeting of soybean-derived sterylglucoside liposomes to liver tumors in rat and mouse models Biol. Pharm. Bull. 21 1998 741 746
134. S. Wang, L. Cheng, F. Yu, W. Pan, and J. Zhang Delivery of different length poly(ε-lysine)-conjugated ODN to HepG2 cells using N-stearyllactobionamide-modified liposomes and their enhanced cellular biological effects Int. J. Pharm. 311 2006 82 88
135. E.A. Biessen, D.M. Beuting, H. Vietsch, M.K. Bijsterbosch, and T.J. Van Berkel Specific targeting of the antiviral drug 5-iodo 2′-deoxyuridine to the parenchymal liver cell using lactosylated poly-ε-lysine J. Hepatol. 21 1994 806 815
136. S.J. Soenen, A.R. Brisson, E. Jonckheere, N. Nuytten, S. Tan, U. Himmelreich, and M. De Cuyper The labeling of cationic iron oxide nanoparticle-resistant hepatocellular carcinoma cells using targeted magnetoliposomes Biomaterials 32 2011 1748 1758
137. K.J. Longmuir, R.T. Robertson, S.M. Haynes, J.L. Baratta, and A.J. Waring Effective targeting of liposomes to liver and hepatocytes in vivo by incorporation of a Plasmodium amino acid sequence Pharm. Res. 23 2006 759 769
138. K. Shimada, J.A.A.M. Kamps, J. Regts, K. Ikeda, T. Shiozawa, S. Hirota, and G.L. Scherphof Biodistribution of liposomes containing synthetic galactose-terminated diacylglyceryl-poly(ethyleneglycol)s Biochim. Biophys. Acta Biomembr. 1326 1997 329 341
139. A. Murao, M. Nishikawa, C. Managit, J. Wong, S. Kawakami, F. Yamashita, and M. Hashida Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition Pharm. Res. 19 2002 1808 1814
140. K. Naicker, M. Ariatti, and M. Singh PEGylated galactosylated cationic liposomes for hepatocytic gene delivery Colloids Surf. B: Biointerfaces 122 2014 482 490
141. M. Nishikawa, Y. Ohtsubo, J. Ohno, T. Fujita, Y. Koyama, F. Yamashita, M. Hashida, and H. Sezaki Pharmacokinetics of receptor-mediated hepatic uptake of glycosylated albumin in mice Int. J. Pharm. 85 1992 75 85
142. P.H. Weigel Characterization of the asialoglycoprotein receptor on isolated rat hepatocytes J. Biol. Chem. 255 1980 6111 6120
143. P.R. Dragsten, D.B. Mitchell, G. Covert, and T. Baker Drug delivery using vesicles targeted to the hepatic asialoglycoprotein receptor Biochim. Biophys. Acta 926 1987 270 279
144. S. Kawakami, C. Munakata, S. Fumoto, F. Yamashita, and M. Hashida Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs J. Pharm. Sci. 90 2001 105 113
145. S. Kawakami, F. Yamashita, M. Nishikawa, Y. Takakura, and M. Hashida Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes Biochem. Biophys. Res. Commun. 252 1998 78 83
146. T. Hara, H. Kuwasawa, Y. Aramaki, S. Takada, K. Koike, K. Ishidate, H. Kato, and S. Tsuchiya Effects of fusogenic and DNA-binding amphiphilic compounds on the receptor-mediated gene transfer into hepatic cells by asialofetuin-labeled liposomes Biochim. Biophys. Acta 1278 1996 51 58
147. Y. Zhang, X. Rong Qi, Y. Gao, L. Wei, Y. Maitani, and T. Nagai Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect J. Control. Release 117 2007 281 290
148. K. Tep, V. Korb, C. Richard, V. Escriou, C. Largeau, V. Vincourt, M. Bessodes, A. Guellier, D. Scherman, L. Cynober, J.C. Chaumeil, and G. Dumortier Formulation and evaluation of ATP-containing liposomes including lactosylated ASGPr ligand J. Liposome Res. 19 2009 287 300
149. L. Hai, Z.-R. Zhang, S. Wang, X. Xiao, and Y. Wu Synthesis of multivalent galactosides as targeting ligand for gene delivery Synth. Commun. 40 2010 1802 1811
150. N. Narainpersad, M. Singh, and M. Ariatti Novel neo glycolipid: formulation into pegylated cationic liposomes and targeting of DNA lipoplexes to the hepatocyte-derived cell line HepG2 Nucleosides Nucleotides Nucleic Acids 31 2012 206 223
151. X. Zhou, M. Zhang, B. Yung, H. Li, C. Zhou, L.J. Lee, and R.J. Lee Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma Int. J. Nanomedicine 7 2012 5465 5474
152. T. Terada, M. Iwai, S. Kawakami, F. Yamashita, and M. Hashida Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting J. Control. Release 111 2006 333 342
153. X. Sun, L. Hai, Y. Wu, H.Y. Hu, and Z.R. Zhang Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD) J. Drug Target. 13 2005 121 128
154. H.A. Cho, I.S. Park, T.W. Kim, Y.K. Oh, K.S. Yang, and J.S. Kim Suppression of hepatitis B virus-derived human hepatocellular carcinoma by NF-kappaB-inducing kinase-specific siRNA using liver-targeting liposomes Arch. Pharm. Res. 32 2009 1077 1086
155. A. McMahon, M.J. O'Neill, E. Gomez, R. Donohue, D. Forde, R. Darcy, and C.M. O'Driscoll Targeted gene delivery to hepatocytes with galactosylated amphiphilic cyclodextrins J. Pharm. Pharmacol. 64 2012 1063 1073
156. N. Jain, V. Rajoriya, P. Jain, and A. Jain Lactosaminated-N-succinyl chitosan nanoparticles for hepatocyte-targeted delivery of acyclovir J. Nanoparticle Res. 16 2013 1 14
157. W. Wang, X. Zhao, H. Hu, D. Chen, J. Gu, Y. Deng, and J. Sun Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability Drug Deliv. 17 2010 114 122
158. X. Li, Q. Wu, Z. Chen, X. Gong, and X. Lin Preparation, characterization and controlled release of liver-targeting nanoparticles from the amphiphilic random copolymer Polymer 49 2008 4769 4775
159. X.L. Zhu, Y.Z. Du, R.S. Yu, P. Liu, D. Shi, Y. Chen, Y. Wang, and F.F. Huang Galactosylated chitosan oligosaccharide nanoparticles for hepatocellular carcinoma cell-targeted delivery of adenosine triphosphate Int. J. Mol. Sci. 14 2013 15755 15766
160. I.S. Kim, and S.H. Kim Development of polymeric nanoparticulate drug delivery systems: evaluation of nanoparticles based on biotinylated poly(ethylene glycol) with sugar moiety Int. J. Pharm. 257 2003 195 203
161. N.K. Jain, and S.K. Jain Development and in vitro characterization of galactosylated low molecular weight chitosan nanoparticles bearing doxorubicin AAPS PharmSciTech 11 2010 686 697
162. Y. Tao, J. He, M. Zhang, Y. Hao, J. Liu, and P. Ni Galactosylated biodegradable poly([varepsilon]-caprolactone-co-phosphoester) random copolymer nanoparticles for potent hepatoma-targeting delivery of doxorubicin Polym. Chem. 5 2014 3443 3452
163. Z. Shen, W. Wei, H. Tanaka, K. Kohama, G. Ma, T. Dobashi, Y. Maki, H. Wang, J. Bi, and S. Dai A galactosamine-mediated drug delivery carrier for targeted liver cancer therapy Pharmacol. Res. 64 2011 410 419
164. H. Li, S. Bian, Y. Huang, J. Liang, Y. Fan, and X. Zhang High drug loading pH-sensitive pullulan-DOX conjugate nanoparticles for hepatic targeting J. Biomed. Mater. Res. A 102 1 2014 150 159
165. S.A. Guhagarkar, R.V. Gaikwad, A. Samad, V.C. Malshe, and P.V. Devarajan Polyethylene sebacate-doxorubicin nanoparticles for hepatic targeting Int. J. Pharm. 401 2010 113 122
166. S. Guhagarkar, S. Majee, A. Samad, and P. Devarajan Evaluation of pullulan-functionalized doxorubicin nanoparticles for asialoglycoprotein receptor-mediated uptake in Hep G2 cell line Cancer Nanotechnol. 2 2011 49 55
167. W. Chen, Y. Zou, F. Meng, R. Cheng, C. Deng, J. Feijen, and Z. Zhong Glyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugs Biomacromolecules 15 2014 900 907
168. J. Lian, S. Zhang, J. Wang, K. Fang, Y. Zhang, and Y. Hao Novel galactosylated SLN for hepatocyte-selective targeting of floxuridinyl diacetate J. Drug Target. 16 2008 250 256
169. J. Varshosaz, F. Hassanzadeh, H. Sadeghi, and M. Khadem Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma J. Liposome Res. 22 2012 224 236
170. M. Guan, Q.L. Zhu, Y. Liu, Y.Y. Bei, Z.L. Gu, X.N. Zhang, and Q. Zhang Uptake and transport of a novel anticancer drug-delivery system: lactosyl-norcantharidin-associated N-trimethyl chitosan nanoparticles across intestinal Caco-2 cell monolayers Int. J. Nanomedicine 7 2012 1921 1930
171. Q. Wang, L. Zhang, W. Hu, Z.H. Hu, Y.Y. Bei, J.Y. Xu, W.J. Wang, X.N. Zhang, and Q. Zhang Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery Nanomedicine 6 2010 371 381
172. W. Lu, L.C. He, C.H. Wang, Y.H. Li, and S.Q. Zhang The use of solid lipid nanoparticles to target a lipophilic molecule to the liver after intravenous administration to mice Int. J. Biol. Macromol. 43 2008 320 324
173. V. Joshi, and P. Devarajan Receptor-mediated hepatocyte-targeted delivery of primaquine phosphate nanocarboplex using a carbohydrate ligand Drug Deliv. Transl. Res. 4 2014 353 364
174. S. Chen, Y.Y.C. Tam, P.J.C. Lin, A.K.K. Leung, Y.K. Tam, and P.R. Cullis Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration J. Control. Release 196 2014 106 112
175. E.F. Craparo, D. Triolo, G. Pitarresi, G. Giammona, and G. Cavallaro Galactosylated micelles for a ribavirin prodrug targeting to hepatocytes Biomacromolecules 14 2013 1838 1849
176. F. Suriano, R. Pratt, J.P. Tan, N. Wiradharma, A. Nelson, Y.Y. Yang, P. Dubois, and J.L. Hedrick Synthesis of a family of amphiphilic glycopolymers via controlled ring-opening polymerization of functionalized cyclic carbonates and their application in drug delivery Biomaterials 31 2010 2637 2645
177. Y. Zhong, W. Yang, H. Sun, R. Cheng, F. Meng, C. Deng, and Z. Zhong Ligand-directed reduction-sensitive shell-sheddable biodegradable micelles actively deliver doxorubicin into the nuclei of target cancer cells Biomacromolecules 14 2013 3723 3730
178. Y. Zou, Y. Song, W. Yang, F. Meng, H. Liu, and Z. Zhong Galactose-installed photo-crosslinked pH-sensitive degradable micelles for active targeting chemotherapy of hepatocellular carcinoma in mice J. Control. Release 193 2014 154 161
179. D. Wakebayashi, N. Nishiyama, Y. Yamasaki, K. Itaka, N. Kanayama, A. Harada, Y. Nagasaki, and K. Kataoka Lactose-conjugated polyion complex micelles incorporating plasmid DNA as a targetable gene vector system: their preparation and gene transfecting efficiency against cultured HepG2 cells J. Control. Release 95 2004 653 664
180. M. Oishi, F. Nagatsugi, S. Sasaki, Y. Nagasaki, and K. Kataoka Smart polyion complex micelles for targeted intracellular delivery of PEGylated antisense oligonucleotides containing acid-labile linkages Chembiochem 6 2005 718 725
181. C. Managit, S. Kawakami, F. Yamashita, and M. Hashida Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells Int. J. Pharm. 301 2005 255 261
182. Y. Hattori, S. Kawakami, F. Yamashita, and M. Hashida Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting J. Control. Release 69 2000 369 377
183. E. Ishida, C. Managit, S. Kawakami, M. Nishikawa, F. Yamashita, and M. Hashida Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice Pharm. Res. 21 2004 932 939
184. R. Villa, B. Cerroni, L. Vigano, S. Margheritelli, G. Abolafio, L. Oddo, G. Paradossi, and N. Zaffaroni Targeted doxorubicin delivery by chitosan-galactosylated modified polymer microbubbles to hepatocarcinoma cells Colloids Surf. B: Biointerfaces 110 2013 434 442
185. W. Wei, Z.G. Yue, J.B. Qu, H. Yue, Z.G. Su, and G.H. Ma Galactosylated nanocrystallites of insoluble anticancer drug for liver-targeting therapy: an in vitro evaluation Nanomedicine (Lond.) 5 2010 589 596
186. C. Duan, J. Gao, D. Zhang, L. Jia, Y. Liu, D. Zheng, G. Liu, X. Tian, F. Wang, and Q. Zhang Galactose-decorated pH-responsive nanogels for hepatoma-targeted delivery of oridonin Biomacromolecules 12 2011 4335 4343
187. H. Arima, S. Yamashita, Y. Mori, Y. Hayashi, K. Motoyama, K. Hattori, T. Takeuchi, H. Jono, Y. Ando, F. Hirayama, and K. Uekama In vitro and in vivo gene delivery mediated by lactosylated dendrimer/α-cyclodextrin conjugates (G2) into hepatocytes J. Control. Release 146 2010 106 117
188. K. Motoyama, Y. Mori, S. Yamashita, Y. Hayashi, H. Jono, Y. Ando, F. Hirayama, K. Uekama, and H. Arima In vitro gene delivery mediated by lactosylated dendrimer (generation 3, G3)/α-cyclodextrin conjugates into hepatocytes J. Incl. Phenom. Macrocycl. Chem. 70 2011 333 338
189. Y. Hayashi, T. Higashi, K. Motoyama, Y. Mori, H. Jono, Y. Ando, and H. Arima Design and evaluation of polyamidoamine dendrimer conjugate with PEG, alpha-cyclodextrin and lactose as a novel hepatocyte-selective gene carrier in vitro and in vivo J. Drug Target. 21 2013 487 496
190. S.H. Medina, V. Tekumalla, M.V. Chevliakov, D.S. Shewach, W.D. Ensminger, and M.E. El-Sayed N-acetylgalactosamine-functionalized dendrimers as hepatic cancer cell-targeted carriers Biomaterials 32 2011 4118 4129
191. D. Bhadra, A.K. Yadav, S. Bhadra, and N.K. Jain Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting Int. J. Pharm. 295 2005 221 233
192. P. Agrawal, U. Gupta, and N.K. Jain Glycoconjugated peptide dendrimers-based nanoparticulate system for the delivery of chloroquine phosphate Biomaterials 28 2007 3349 3359
193. H. Arima, K. Motoyama, and T. Higashi Potential use of polyamidoamine dendrimer conjugates with cyclodextrins as novel carriers for siRNA Pharmaceuticals (Basel) 5 2012 18
194. A.M. Pujol, M. Cuillel, O. Renaudet, C. Lebrun, P. Charbonnier, D. Cassio, C. Gateau, P. Dumy, E. Mintz, and P. Delangle Hepatocyte targeting and intracellular copper chelation by a thiol-containing glycocyclopeptide J. Am. Chem. Soc. 133 2011 286 296
195. X. Wang, D.P. Sarkar, P. Mani, C.J. Steer, Y. Chen, C. Guha, V. Chandrasekhar, A. Chaudhuri, N. Roy-Chowdhury, B.T. Kren, and J. Roy-Chowdhury Long-term reduction of jaundice in Gunn rats by nonviral liver-targeted delivery of Sleeping Beauty transposon Hepatology 50 2009 815 824
196. M. Hohokabe, Y. Higuchi, H. Mukai, S. Kawakami, and M. Hashida Hepatocyte-selective gene transfer by galactosylated protein/linear polyethyleneimine/plasmid DNA complexes in mice J. Biomed. Nanotechnol. 3 2007 277 284
197. T.H. Kim, S.I. Kim, T. Akaike, and C.S. Cho Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes J. Control. Release 105 2005 354 366
198. E.H. Hwang, J. Taki, N. Shuke, K. Nakajima, S. Kinuya, S. Konishi, T. Michigishi, T. Aburano, and N. Tonami Preoperative assessment of residual hepatic functional reserve using 99mTc-DTPA-galactosyl-human serum albumin dynamic SPECT J. Nucl. Med. 40 1999 1644 1651
199. Y. Iimuro, T. Kashiwagi, J. Yamanaka, T. Hirano, S. Saito, T. Sugimoto, S. Watanabe, N. Kuroda, T. Okada, Y. Asano, N. Uyama, and J. Fujimoto Preoperative estimation of asialoglycoprotein receptor expression in the remnant liver from CT/99mTc-GSA SPECT fusion images correlates well with postoperative liver function parameters J. Hepatobiliary Pancreat. Sci. 17 2010 673 681
200. Y. Yumoto, T. Yagi, S. Sato, K. Nouso, Y. Kobayashi, M. Ohmoto, E. Yumoto, I. Nagaya, and H. Nakatsukasa Preoperative estimation of remnant hepatic function using fusion images obtained by 99mTc-labelled galactosyl-human serum albumin liver scintigraphy and computed tomography Br. J. Surg. 97 2010 934 944
201. M. Yoshida, S. Shiraishi, F. Sakaguchi, D. Utsunomiya, K. Tashiro, S. Tomiguchi, H. Okabe, T. Beppu, H. Baba, and Y. Yamashita Fused 99m-Tc-GSA SPECT/CT imaging for the preoperative evaluation of postoperative liver function: can the liver uptake index predict postoperative hepatic functional reserve? Jpn. J. Radiol. 30 2012 255 262
202. M. Kaibori, S.K. Ha-Kawa, M. Maehara, M. Ishizaki, K. Matsui, S. Sawada, and A.H. Kwon Usefulness of Tc-99m-GSA scintigraphy for liver surgery Ann. Nucl. Med. 25 2011 593 602
203. R. Haubner, D.R. Vera, S. Farshchi-Heydari, A. Helbok, C. Rangger, D. Putzer, and I.J. Virgolini Development of (6)(8)Ga-labelled DTPA galactosyl human serum albumin for liver function imaging Eur. J. Nucl. Med. Mol. Imaging 40 2013 1245 1255
204. M. Yoshinori, M. Masaharu, H. Yuri, N. Sayoko, S. Nao, and H. Makoto Molecular imaging contrast media for visualization of liver function Magn. Reson. Imaging 28 2010 708 715
205. K.M. Kamruzzaman Selim, Y.S. Ha, S.J. Kim, Y. Chang, T.J. Kim, G. Ho Lee, and I.K. Kang Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes Biomaterials 28 2007 710 716
206. D.L. Schmucker Age-related changes in liver structure and function: implications for disease? Exp. Gerontol. 40 2005 650 659
207. K.A. Deal, M.E. Cristel, and M.J. Welch Cellular distribution of 111In-LDTPA galactose BSA in normal and asialoglycoprotein receptor-deficient mouse liver Nucl. Med. Biol. 25 1998 379 385
208. K. Ogawara, M. Nishikawa, Y. Takakura, and M. Hashida Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver J. Control. Release 50 1998 309 317
209. L.J. Wu, Y.D. Pan, X.Y. Pei, H. Chen, S. Nguyen, A. Kashyap, J. Liu, and J. Wu Capturing circulating tumor cells of hepatocellular carcinoma Cancer Lett. 326 2012 17 22
210. W. Xu, L. Cao, L. Chen, J. Li, X.F. Zhang, H.H. Qian, X.Y. Kang, Y. Zhang, J. Liao, L.H. Shi, Y.F. Yang, M.C. Wu, and Z.F. Yin Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy Clin. Cancer Res. 17 2011 3783 3793
211. W.-J. Lin, and M.H. Chen Synthesis of multifunctional chitosan with galactose as a targeting ligand for glycoprotein receptor Carbohydr. Polym. 67 2007 474 480
212. S.K. Ha-Kawa, Y. Tanaka, S. Hasebe, Y. Kuniyasu, K. Koizumi, Y. Ishii, K. Yamamoto, T. Kashiwagi, A. Ito, M. Kudo, K. Ikekubo, T. Tsuda, and K. Murase Compartmental analysis of asialoglycoprotein receptor scintigraphy for quantitative measurement of liver function: a multicentre study Eur. J. Nucl. Med. 24 1997 130 137
213. W. Yang, Z. Zhao, W. Fang, and X. Zhang The preparation of 99mTc-DTPA-LSA and its instant lyophilized kit for hepatic receptor imaging Appl. Radiat. Isot. 74 2013 1 5
214. C. Richard, P. Chaumet-Riffaud, A. Belland, A. Parat, C. Contino-Pepin, M. Bessodes, D. Scherman, B. Pucci, and N. Mignet Amphiphilic perfluoroalkyl carbohydrates as new tools for liver imaging Int. J. Pharm. 379 2009 301 308
215. J. Peng, K. Wang, W. Tan, X. He, C. He, P. Wu, and F. Liu Identification of live liver cancer cells in a mixed cell system using galactose-conjugated fluorescent nanoparticles Talanta 71 2007 833 840
216. D.Q. Wu, B. Lu, C. Chang, C.S. Chen, T. Wang, Y.Y. Zhang, S.X. Cheng, X.J. Jiang, X.Z. Zhang, and R.X. Zhuo Galactosylated fluorescent labeled micelles as a liver targeting drug carrier Biomaterials 30 2009 1363 1371
217. S.H. Yang, D. Heo, E. Lee, E. Kim, E.K. Lim, Y.H. Lee, S. Haam, J.S. Suh, Y.M. Huh, J. Yang, and S.W. Park Galactosylated manganese ferrite nanoparticles for targeted MR imaging of asialoglycoprotein receptor Nanotechnology 24 2013 475103
218. R. Kikkeri, B. Lepenies, A. Adibekian, P. Laurino, and P.H. Seeberger In vitro imaging and in vivo liver targeting with carbohydrate capped quantum dots J. Am. Chem. Soc. 131 2009 2110 2112
219. A. Ketkar-Atre, T. Struys, T. Dresselaers, M. Hodenius, I. Mannaerts, Y. Ni, I. Lambrichts, L.A. Van Grunsven, M. De Cuyper, and U. Himmelreich In vivo hepatocyte MR imaging using lactose functionalized magnetoliposomes Biomaterials 35 2014 1015 1024
220. G. Hausdorf, D. Roggenbuck, E. Feist, T. Buttner, P.R. Jungblut, K. Conrad, C. Berg, and R. Klein Autoantibodies to asialoglycoprotein receptor (ASGPR) measured by a novel ELISA - revival of a disease-activity marker in autoimmune hepatitis Clin. Chim. Acta 408 2009 19 24
221. P.H. Weigel Rat hepatocytes bind to synthetic galactoside surfaces via a patch of asialoglycoprotein receptors J. Cell Biol. 87 1980 855 861
222. H. Ise, A. Ferdous, N. Sugihara, T. Nikaido, N. Negishi, and T. Akaike Separation of mouse hepatocytes of distinct biological phenotypes based on their asialoglycoprotein receptor-mediated adhesion to an artificial ligand J. Artif. Organs 4 2001 342 347
223. C. Yin, L. Ying, P.C. Zhang, R.X. Zhuo, E.T. Kang, K.W. Leong, and H.Q. Mao High density of immobilized galactose ligand enhances hepatocyte attachment and function J. Biomed. Mater. Res. A 67 2003 1093 1104
224. T. Mizuguchi, T. Mitaka, T. Katsuramaki, and K. Hirata Hepatocyte transplantation for total liver repopulation J. Hepatobiliary Pancreat. Surg. 12 2005 378 385
225. H. Yura, M. Ishihara, S. Nakamura, S. Kishimoto, Y. Kanatani, T. Horio, T. Ishizuka, M. Kawakami, and T. Matsui Coatings of low-density lipoprotein and synthetic glycoconjugates as substrata for hepatocytes Artif. Organs 33 2009 419 424
226. T.W. Chung, J. Yang, T. Akaike, K.Y. Cho, J.W. Nah, S.I. Kim, and C.S. Cho Preparation of alginate/galactosylated chitosan scaffold for hepatocyte attachment Biomaterials 23 2002 2827 2834
227. J. Yang, M. Goto, H. Ise, C.S. Cho, and T. Akaike Galactosylated alginate as a scaffold for hepatocytes entrapment Biomaterials 23 2002 471 479
228. I.K. Park, J. Yang, H.J. Jeong, H.S. Bom, I. Harada, T. Akaike, S.I. Kim, and C.S. Cho Galactosylated chitosan as a synthetic extracellular matrix for hepatocytes attachment Biomaterials 24 2003 2331 2337
229. S.J. Seo, I.Y. Kim, Y.J. Choi, T. Akaike, and C.S. Cho Enhanced liver functions of hepatocytes cocultured with NIH 3T3 in the alginate/galactosylated chitosan scaffold Biomaterials 27 2006 1487 1495
230. Y. Gotoh, S. Niimi, T. Hayakawa, and T. Miyashita Preparation of lactose-silk fibroin conjugates and their application as a scaffold for hepatocyte attachment Biomaterials 25 2004 1131 1140
231. S. Chernyy, B.E.B. Jensen, K. Shimizu, M. Ceccato, S.U. Pedersen, A.N. Zelikin, K. Daasbjerg, and J. Iruthayaraj Surface grafted glycopolymer brushes to enhance selective adhesion of HepG2 cells J. Colloid Interface Sci. 404 2013 207 214
232. C.S. Cho, K.Y. Cho, I.K. Park, S.H. Kim, T. Sasagawa, M. Uchiyama, and T. Akaike Receptor-mediated delivery of all trans-retinoic acid to hepatocyte using poly(L-lactic acid) nanoparticles coated with galactose-carrying polystyrene J. Control. Release 77 2001 7 15
233. S.J. Seo, T. Akaike, Y.J. Choi, M. Shirakawa, I.K. Kang, and C.S. Cho Alginate microcapsules prepared with xyloglucan as a synthetic extracellular matrix for hepatocyte attachment Biomaterials 26 2005 3607 3615
234. C.S. Cho, S.J. Seo, I.K. Park, S.H. Kim, T.H. Kim, T. Hoshiba, I. Harada, and T. Akaike Galactose-carrying polymers as extracellular matrices for liver tissue engineering Biomaterials 27 2006 576 585
235. D. Trere, L. Fiume, L.B. De Giorgi, G. Di Stefano, M. Migaldi, and M. Derenzini The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells Br. J. Cancer 81 1999 404 408
236. S. Matsuzaki, M. Onda, T. Tajiri, and D.Y. Kim Hepatic lobar differences in progression of chronic liver disease: correlation of asialoglycoprotein scintigraphy and hepatic functional reserve Hepatology 25 1997 828 832
237. G. DiStefano, C. Busi, P. Chieco, M. Pariali, and L. Fiume Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas Dig. Liver Dis. 38 2006 2
238. D. Roggenbuck, M. Mytilinaiou, S. Lapin, D. Reinhold, and K. Conrad Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity Autoimmun. Highlights 3 2012 119 125
239. C. Diaz, E. Vargas, and O. Gatjens-Boniche Cytotoxic effect induced by retinoic acid loaded into galactosyl-sphingosine containing liposomes on human hepatoma cell lines Int. J. Pharm. 325 2006 108 115
240. M.K. Bijsterbosch, and T.J. Van Berkel Uptake of lactosylated low-density lipoprotein by galactose-specific receptors in rat liver Biochem. J. 270 1990 233 239
241. A.R. Kolatkar, and W.I. Weis Structural basis of galactose recognition by C-type animal lectins J. Biol. Chem. 271 1996 6679 6685
242. L. Dong, S. Gao, H. Diao, J. Chen, and J. Zhang Galactosylated low molecular weight chitosan as a carrier delivering oligonucleotides to Kupffer cells instead of hepatocytes in vivo J. Biomed. Mater. Res. A 84 2008 777 784
243. L. Fiume, C. Busi, G. Di Stefano, and A. Mattioli Targeting of antiviral drugs to the liver using glycoprotein carriers Adv. Drug Deliv. Rev. 14 1994 51 65
244. P. Sun, Y. He, M. Lin, Y. Zhao, Y. Ding, G. Chen, and M. Jiang Glyco-regioisomerism effect on lectin-binding and cell-uptake pathway of glycopolymer-containing nanoparticles ACS Macro Lett. 3 2013 96 101